BPI-421286
- Generic Name
- BPI-421286
A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT05315180
- Locations
- 🇨🇳
Wen Li, Ph.D, Hangzhou, Zhejiang, China
🇨🇳Yun Fan,Ph.D, Hangzhou, Zhejiang, China
🇨🇳Shun Lu, Ph.D, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath